The global Biophotonics market was valued at US$70.4 billion in 2025 and is projected to reach US$123 billion by 2032, registering a CAGR of 8.3% during 2025-2032. Market growth is being driven by rising utilization of advanced imaging systems, growing demand for molecular diagnostics, increasing adoption of biosensors, and continuous technological innovation in in-vivo and in-vitro applications. Imaging remains the largest application area, supported by strong demand for see-through imaging, endoscopy, and surface imaging technologies. Medical diagnostics represents the largest end-use sector, while non-medical applications are emerging as the fastest-growing area. Asia-Pacific is expected to outpace other regions in growth, reflecting expanding healthcare infrastructure, increasing research activities, and broader adoption of advanced biophotonic technologies.
Biophotonics Regional Market Analysis
In 2025, North America was the largest regional segment in the Biophotonics market, accounting for 38.7% of total market revenue. Europe ranked as the second-largest region, Asia-Pacific followed closely. Among all regions, Asia-Pacific is projected to record the fastest growth at a 10% CAGR during 2025-2032, reaching US$32.6 billion by 2032 and increasing its market share to 26.5%.Biophotonics Market Analysis by Application & Sub-type
Imaging was the largest application segment in the Biophotonics market in 2025, valued at US$39 billion, followed by Analytics & Sensing. Within Analytics & Sensing, Molecular Spectroscopy dominated with a 64.3% share, with Biosensors projected to be the fastest-growing sub-type. Within Imaging, See-Through Imaging led with US$16.6 billion, while Surface Imaging is forecast to be the fastest-growing sub-type at a 9.3% CAGR. In the Processing & Curing segment, Light Therapy overwhelmingly dominated with 82.5% share, and is also expected to remain the faster-growing sub-type.Biophotonics Market Analysis by Technology
In 2025, In-Vivo was the leading technology segment in the Biophotonics market, valued at US$39.5 billion and accounting for 56.2% of total market revenue. During 2025-2032, In-Vivo is projected to remain the fastest-growing technology, registering an 8.5% CAGR and reaching US$70 billion by 2032.Biophotonics Market Analysis by End-Use Sector
Medical Diagnostics was the dominant end-use sector in the Biophotonics market in 2025, accounting for 68% of total market revenue. Medical Therapeutics ranked as the second-largest sector with US$11.8 billion, followed by Tests & Components. During 2025-2032, Non-Medical Applications is projected to be the fastest-growing end-use sector, registering a 9.2% CAGR and reaching US$5.6 billion by 2032.Biophotonics Market Report Scope
This global report on Biophotonics analyzes the market based on application & sub-type, technology and end-use sector for the period 2022-2032 with projections from 2025 to 2032 in terms of value in US$. In addition to providing profiles of major companies operating in the Biophotonics industry, the latest corporate, product and industrial developments have been covered to offer a clear panorama of Biophotonics industry.Key Metrics
- Historical Period: 2022-2025
- Base Year: 2025
- Forecast Period: 2025-2032
- Units: Value market in US$
- Companies Mentioned: 25+
Global Biophotonics Market by Geographic Region
- North America (The United States and Canada)
- Europe (France, Germany, Italy, The United Kingdom, Italy and Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea and Rest of Asia-Pacific)
- Latin America (Argentina, Brazil, Mexico and Rest of Latin America)
- Rest of World
Global Biophotonics Market by Application & Sub-type
- Analytics & Sensing
- Imaging
- Processing & Curing
Global Biophotonics Market by Technology
- In-Vitro
- In-Vivo
Global Biophotonics Market by End-Use Sector
- Medical Diagnostics
- Medical Therapeutics
- Tests & Components
- Non-Medical Applications
This product will be delivered within 2-4 business days.
Table of Contents
Companies Mentioned
- Agilent Technologies Inc. (Biotek Instruments, Inc.)
- Becton, Dickinson and Company
- Biolase, Inc.
- Bio-Rad Laboratories, Inc.
- Carl Zeiss AG
- Coherent Inc.
- Hamamatsu Photonics K.K.
- Horiba, Ltd.
- Lumenis Ltd.
- Newport Corporation
- Olympus Corporation
- Perkinelmer Inc.
- Picoquant
- Thermo Fisher Scientific Inc.
- Toshiba Medical Systems Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 465 |
| Published | July 2026 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value ( USD | $ 70.4 Billion |
| Forecasted Market Value ( USD | $ 123 Billion |
| Compound Annual Growth Rate | 8.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |


